COURTNEY BELLINGER: Open Payments
NPI 1487422572 · HARRISBURG, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,484 in 74 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $434 · 2025 $1,484
Food & beverage: $1,484
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 17 | $325 |
| ABBVIE INC. | 17 | $257 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $227 |
| Otsuka America Pharmaceutical, Inc. | 7 | $135 |
| Tris Pharma Inc | 7 | $128 |
| Neurocrine BioSciences, Inc. | 5 | $116 |
| Vanda Pharmaceuticals Inc. | 1 | $92 |
| Janssen Pharmaceuticals, Inc | 4 | $79 |
| Lundbeck LLC | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
Products named: Auvelity, VRAYLAR, CAPLYTA, Dyanavel XR, INGREZZA, REXULTI, FANAPT, SPRAVATO.
Industry payments across AR — which companies pay providers there.
